-+ 0.00%
-+ 0.00%
-+ 0.00%

ANIXA BIOSCIENCES - BREAST CANCER VACCINE PHASE 1 TRIAL MEETS ALL MAJOR PRIMARY ENDPOINTS

Reuters·06/26/2026 13:10:00

Please log in to view news